Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114799912 | 11479991 | 2 | F | 2013 | 20160920 | 20150909 | 20160928 | EXP | US-JAZZ-2014-US-014830 | JAZZ | 0.00 | M | Y | 83.90000 | KG | 20160928 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114799912 | 11479991 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | U | 21196 | 2.25 | G | ORAL SOLUTION | ||||||
| 114799912 | 11479991 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | U | 21196 | 3 | G | ORAL SOLUTION | ||||||
| 114799912 | 11479991 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | U | 21196 | 3.75 | G | ORAL SOLUTION | ||||||
| 114799912 | 11479991 | 4 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | |||||||
| 114799912 | 11479991 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | |||||||
| 114799912 | 11479991 | 6 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | |||||||
| 114799912 | 11479991 | 7 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | Topical | U | 0 | ||||||||||
| 114799912 | 11479991 | 8 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | Nasal | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114799912 | 11479991 | 1 | Narcolepsy |
| 114799912 | 11479991 | 2 | Cataplexy |
| 114799912 | 11479991 | 3 | Somnolence |
| 114799912 | 11479991 | 4 | Blood cholesterol increased |
| 114799912 | 11479991 | 5 | Hypertension |
| 114799912 | 11479991 | 6 | Hypersensitivity |
| 114799912 | 11479991 | 7 | Dandruff |
| 114799912 | 11479991 | 8 | Hypersensitivity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114799912 | 11479991 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114799912 | 11479991 | Blood pressure abnormal | |
| 114799912 | 11479991 | Conjunctivitis | |
| 114799912 | 11479991 | Cyst | |
| 114799912 | 11479991 | Dacryostenosis acquired | |
| 114799912 | 11479991 | Dyspepsia | |
| 114799912 | 11479991 | Fatigue | |
| 114799912 | 11479991 | Gastrointestinal disorder | |
| 114799912 | 11479991 | Herpes virus infection | |
| 114799912 | 11479991 | Hypogonadism | |
| 114799912 | 11479991 | Inguinal hernia | |
| 114799912 | 11479991 | Irritability | |
| 114799912 | 11479991 | Ligament sprain | |
| 114799912 | 11479991 | Pain | |
| 114799912 | 11479991 | Weight decreased | |
| 114799912 | 11479991 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114799912 | 11479991 | 1 | 200803 | 200804 | 0 | |
| 114799912 | 11479991 | 2 | 200804 | 2008 | 0 | |
| 114799912 | 11479991 | 3 | 200807 | 0 |